Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Red~Oneon Jun 09, 2022 1:42pm
212 Views
Post# 34744412

Nitric Oxide in the news but not CLAS

Nitric Oxide in the news but not CLAS

Where are the COVID-19 Nasal Sprays?

 
Where are the COVID-19 Nasal Sprays?

.

COVID-19 Enters the Human Body Through the Nose or Mouth, so Where are the COVID-19 Nasal Sprays? Much of our attention during the pandemic has focused on vaccines, face masks, and ventilation. But with the current hyper-transmissibility of Omicron and the not insignificant problems associated with long covid (which can result even from very mild illness in vaccinated people), many would like additional prophylactic measures to reduce the risk of infection. Enter nasal sprays.

Nitric Oxide Nasal Spray

At least one nasal spray is already approved for use in several countries, although not yet (at time of writing) in the U.S. or in Canada, where the company is based. A Nitric Oxide Nasal Spray developed by Vancouver-based SaNOtize kills the coronavirus in the upper airways, keeping it from incubating and spreading to the lungs. A UK study confirmed a rapid 95% reduction in viral load within 24 hours of using the nasal spray in infected adults (99% within 72 hours), while a recent Thai study of individuals quarantined after a high risk exposure to an infected contact found that of those who used the nasal spray, only 6.4% became infected, vs. 25.6% of those who didn't use the nasal spray; nearly quadruple the number. A Phase 3 randomized, double-blind, placebo controlled trial in India reduced the SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours.

“The SaNOtize nasal spray…contains nitric oxide, which prevents and treats early infection by destroying the virus and impeding viral replication within the cells in the nose. In addition, nitric oxide has been shown to block the ACE2 receptor essential for the virus to infect our cells,” says Dr Chris Miller, Chief Science Officer and Co-Founder of SaNOtize.  

To date, SaNOtize has been approved and is produced in Israel under the Enovid brand, and in India under the FabiSpray brand; the spray is also approved and sold in Thailand, Indonesia and Bahrain. Canada has approved a Phase 3 clinical trial.

Unfortunately, it doesn't seem as though SaNOtize's nasal spray will be approved in the U.S. soon, but that hasn't stopped enterprising companies from importing it from Israel to sell to consumers.

If you're a reader in Israel, India, or another country where SaNOtize's nasal spray is sold and have been using the product, how well has it worked for you?


<< Previous
Bullboard Posts
Next >>